Deborah Phippard, PhD, on the Future of Gene Therapy in Neurology
The chief scientific officer of Precision for Medicine discussed what lies on the horizon for gene therapies directed at neurological indications, such as Alzheimer disease and Parkinson disease.
Deborah Phippard, PhD, on Designing Clinical Trials for Gene Therapies in Neurological Indications
The chief scientific officer of Precision for Medicine discussed the unique aspects of clinical trials for gene therapies that need to be considered before initiation.
Deborah Phippard, PhD, on the History and Current State of Gene Therapy for Neurological Indications
The chief scientific officer of Precision for Medicine discussed the previous and current delivery methods used for gene therapies and new innovations on the horizon.